May 20, 2024 2:35 am
Biomed Israel 2024: Conference to be Attended by Senior Executives from the Global Life Sciences Industry

The Biomed Israel conference is set to attract top senior officials from the healthcare industry. Some of the key figures scheduled to participate include Richard Francis, Dr. Aharon (Roni) Gal, Prof. Yitzhak Kreis, Dr. Boaz Hirshberg, Dr. Gil Bar-Nahum, Dror Bin, Barry Green, Guy Hadari, Stanley Lapidus, Dr. Joseph Koresh and Dr. Avi Tzur among others. These leaders will gather for three intense days of networking to drive business opportunities and promote collaborations within the healthcare sector.

The conference is Israel’s largest meeting place for healthcare professionals with over 100 Israeli companies presenting solutions and technologies developed in various fields such as life sciences and biomedicine. Visitors will have a unique opportunity to experience Israel’s innovative environment in these industries.

The event will cover a range of topics including biopharma, medical devices, digital health and diagnostic products. Lectures and discussion sessions will be held on the latest trends and breakthroughs in medicine such as women’s health, home hospitalization, AI impact on drug discovery, healthy aging genetic medicine and brain health among others.

Ruthie Alon, founder and CEO of Medstrada and co-chair of the conference expressed pride in bringing together experts to discuss topics ranging from disease treatment models to turning medical data into knowledge. Meanwhile Dr. Ora Der and Dr. Nissim Darvish who are also co-chairs of the conference highlighted Israel’s innovative contributions to life sciences medical technologies and the role played by Innovation Authority in supporting industry success.

Overall this conference promises to be an exciting opportunity for professionals in the healthcare sector to network with leaders from industry while learning about cutting edge technologies developed in Israel that have global implications for healthcare delivery.

Leave a Reply